Doxorubicin
Cold Chain RequiredFDA Approved, EMA Approved
Contents
Description
Doxorubicin is an anthracycline antibiotic that intercalates DNA and inhibits topoisomerase II, leading to DNA damage and cell death. It is widely used in the treatment of various sarcomas including extraskeletal myxoid chondrosarcoma as part of combination chemotherapy regimens. It has broad activity against multiple malignancies.
Indications & Therapeutic Use
soft tissue sarcoma, extraskeletal myxoid chondrosarcoma, breast cancer, lymphoma, acute leukemia
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Doxorubicin — GNH India
206 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Adriacept Blasen-Instillations-Set
EU
Adriamycin
EU
Adriamycin Rapid Dissolution
50mg
Adriblastin
EU
Adriblastina
EU
Adriblastina Ready To Use
EU
Adriblastine
EU
Adrimedac
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Doxorubicin
| Generic Name | doxorubicin |
| Brands | 1 brand available |
| Active Ingredient | doxorubicin hydrochloride |
| Drug Class | soft tissue sarcoma |
| Manufacturer | Multiple manufacturers |
| Dosage Forms | IV injection, 2 mg/mL solution |
| Medical Code | L01DB01 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT00003052 |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes